The global Human Growth Hormone (HGH) market is witnessing a paradigm shift driven by aging populations and pediatric endocrinology advancements. As a leading China Human Growth Hormone Manufacturer, Gentolex is at the forefront of this $5.2B industry, providing scalable recombinant DNA technology (rDNA) solutions.
Our production utilizes E. coli expression systems and high-throughput chromatography to ensure 191-amino acid sequence identity. We prioritize protein stability and lyophilization techniques to maintain biological activity during trans-continental shipping.
Operating under cGMP standards, our facilities feature 250,000 square meters of international-grade cleanrooms. We provide full COA, HPLC, and MS validation for every batch, ensuring E-E-A-T reliability for global pharmaceutical partners.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Providing research-grade HGH and peptides like Epithalon and Selank for academic and clinical trials, ensuring rigorous data integrity.
Strategic warehousing in Mexico and South Africa to reduce lead times and navigate complex importation regulations for biologic agents.
Tailored peptide sequences and concentration variants (e.g., 5mg, 10mg, 30mg) to meet specific therapeutic or commercial requirements.
Neuropharmacological research derivative for cognitive and anxiety-related study. Synthetic heptapeptide excellence.
Biological activities related to tissue repair and angiogenesis. Trusted Tβ4 peptide API supplier.
Focusing on gastrointestinal protection and inflammatory regulation research through synthetic pentadecapeptides.
